3 Non-Surgical Regenerative Pain Treatment Centers for Sale
Business Description
REGENERATIVE MEDICINE FRANCHISE PORTFOLIO
This acquisition of 3 Non-Surgical regenerative pain treatment centers serving Austin healthcare market. The franchisor has maintained continuous operations for similar locations across the country with established patient revenue streams and documented financial performance.
CLINICAL OPERATIONS
The centers deliver evidence-based regenerative medicine treatments utilizing advanced protocols including Class IV deep tissue laser therapy, platelet-rich plasma (PRP) injections, placental tissue therapy, bone marrow stem cell treatments, and A2M therapy. Clinical services target chronic pain conditions including arthritis, injury-related disorders, and repetitive stress injuries affecting joints, muscles, tendons, ligaments, cartilage, and connective tissue.
OPERATIONAL FRAMEWORK
Each facility operates one day weekly under a Management Services Organization (MSO) structure. Corporate headquarters provides comprehensive operational support including medical oversight, staff recruitment and training, financial management, and regulatory compliance. Centralized marketing campaigns generate patient referrals while a unified call center manages appointment scheduling across all locations.
FINANCIAL STRUCTURE
The business operates on a cash-pay model with average patient treatment values of $6,000, eliminating insurance reimbursement complexities and reducing administrative overhead. This direct-pay structure enhances profit margins and streamlines revenue collection processes.
MARKET POSITION
The regenerative medicine sector demonstrates significant growth trajectory, with industry projections indicating expansion from $13.3 billion to $38.7 billion by 2024. This growth reflects increasing demand for non-invasive pain management alternatives and advancing medical technologies.
INVESTMENT CHARACTERISTICS
The opportunity requires no medical licensure as corporate management maintains clinical oversight and operational execution. The semi-passive ownership structure accommodates absentee management, suitable for investment portfolio diversification. Approximately 80% of licensing and regulatory framework completion reduces implementation timeline to 4-6 months per clinic.
The franchise model offers scalability potential and integration opportunities for existing healthcare facilities seeking revenue enhancement, including medical practices, senior care facilities, and alternative healthcare providers.
This acquisition of 3 Non-Surgical regenerative pain treatment centers serving Austin healthcare market. The franchisor has maintained continuous operations for similar locations across the country with established patient revenue streams and documented financial performance.
CLINICAL OPERATIONS
The centers deliver evidence-based regenerative medicine treatments utilizing advanced protocols including Class IV deep tissue laser therapy, platelet-rich plasma (PRP) injections, placental tissue therapy, bone marrow stem cell treatments, and A2M therapy. Clinical services target chronic pain conditions including arthritis, injury-related disorders, and repetitive stress injuries affecting joints, muscles, tendons, ligaments, cartilage, and connective tissue.
OPERATIONAL FRAMEWORK
Each facility operates one day weekly under a Management Services Organization (MSO) structure. Corporate headquarters provides comprehensive operational support including medical oversight, staff recruitment and training, financial management, and regulatory compliance. Centralized marketing campaigns generate patient referrals while a unified call center manages appointment scheduling across all locations.
FINANCIAL STRUCTURE
The business operates on a cash-pay model with average patient treatment values of $6,000, eliminating insurance reimbursement complexities and reducing administrative overhead. This direct-pay structure enhances profit margins and streamlines revenue collection processes.
MARKET POSITION
The regenerative medicine sector demonstrates significant growth trajectory, with industry projections indicating expansion from $13.3 billion to $38.7 billion by 2024. This growth reflects increasing demand for non-invasive pain management alternatives and advancing medical technologies.
INVESTMENT CHARACTERISTICS
The opportunity requires no medical licensure as corporate management maintains clinical oversight and operational execution. The semi-passive ownership structure accommodates absentee management, suitable for investment portfolio diversification. Approximately 80% of licensing and regulatory framework completion reduces implementation timeline to 4-6 months per clinic.
The franchise model offers scalability potential and integration opportunities for existing healthcare facilities seeking revenue enhancement, including medical practices, senior care facilities, and alternative healthcare providers.
About the Business
- Years in Operation
- 6
- Employees
- 12 (8 Full-time, 4 Part-time)
- Franchise
- This business is an established franchise
- Market Outlook / Competition
- Tremendous opportunity to join the market leader in the regenerative medicine market with a national brand.
- Opportunities for Growth
- The Regenerative Medicine Market is estimated to be valued at 13.3 billion and projected to reach 48.97 billion by 2025.
Real Estate
- Owned or Leased
- Leased
- Building Sq. Ft.
- 1,200
About the Sale
- Transition Support
- Full Franchisor provides transition training and on-going support
Listing Info
- ID
- 2451599
- Listing Views
Listing ID: 2451599 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.










